AbbVie Inc.
ABBV · Healthcare · · USDFahodi Score BUY Short-term (Swing)
72
/ 100
Technical
75
Trend & RS
95
Momentum
81
Fundamental (0%)
44
Macro
22
Liquidity
78
| Component | Score | Weight |
|---|---|---|
| Technical | 75.0 | 40% |
| Trend & RS | 94.7 | 20% |
| Momentum | 81.2 | 20% |
| Fundamental | 44.4 | 0% |
| Macro | 22.5 | 15% |
| Liquidity | 77.5 | 5% |
Trade Setup
| Entry | 288.24 |
| Stop Loss | 273.10 (5.2%) |
| Target 1 (1:1) | 303.38 (+5.2%) |
| Target 2 (2:1) | 318.52 (+10.5%) |
| ATR(14) | 7.57 (2.6%) |
| Risk per Share | 15.14 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 1.1 | -1.96 | |
| Momentum | 81.2 | +1.25 | |
| Quality | 31.0 | -0.76 | |
| Composite | 37.7 | ||
Quality Scores
Piotroski F-Score
4
/9 —
Average
✓
✗
✗
✗
✗
✗
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 49.5 | 22.0 | +125% above |
| P/B Ratio | -111.2 | 4.0 | Inline |
| Dividend Yield | 2.4% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
102.03
vs
Market Price
288.24
Upside
-64.6%
| Margin of Safety | -182.5% |
| Stage 1 PV (5yr FCF) | 42,646,073,106 |
| Terminal Value PV | 137,707,164,337 |
| Total Enterprise Value | 180,353,237,443 |
Assumptions
| Base FCF | 8,230,021,204 |
| Growth Rate (5yr) | 10.3% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
47.17%
Full Kelly
23.58%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 72/100. Estimated win rate 62%, avg win 9.3%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
3
Bullish Signals
1
Bearish Signals
57.49
RSI(14)
6.0347
MACD
Relative Strength (RS) STRONG RS
86
/ 99
RS Rating
✓ O'Neil PASS (≥80)
| RS vs SPY | ↑ RISING (+22.8% vs SPY 3M) |
| RS vs Sector | OUTPERFORMING (Healthcare) |
| RS New High | ✓ RS at 3-month high Institutional accumulation signal |
| Sector Outperformance | +4.9% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
STRONG RS:
Top performer — outperforming the market and making new relative highs. Institutional accumulation likely.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 57.49 | NEUTRAL |
| Macd | 6.0347 | BEARISH |
| Ma Cross | 270.19 / 235.83 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 1.42x | NORMAL |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 302.93 |
| Bollinger Upper | 296.43 |
| SMA(200) | 235.83 |
| SMA(50) | 270.19 |
| SMA(20) | 285.38 |
| Current Price | 288.24 |
| Bollinger Lower | 274.32 |
| 52-Week Low | 190.75 |
| ATR(14) | 7.57 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
DISTRIBUTION C
Confidence
56%
Upthrust (potential)
Acc: 0.0 |
Dist: 2.5 |
Markup: 2.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-10-30 | Normal | 1.23x | Normal bar — no special VSA pattern |
| 2026-11-02 | Normal | 1.57x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.95x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.5x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.42x | Normal bar — no special VSA pattern |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 292.08 | Above Kijun |
| Kijun-sen (26) | 279.61 | Base line |
| Senkou A | 285.85 | Leading span A |
| Senkou B | 274.10 | Leading span B |
| Cloud | 274.10 – 285.85 | Bullish (Green) |
| Price vs Cloud | 288.24 | Above Cloud |
| Chikou Span | 258.34 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE ON
1 bars
Momentum:
BULLISH FADING
BB: 274.32 – 296.43 | KC: 273.93 – 296.83
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Regular Bearish | MACD | 5 |
Anchored VWAP
VWAP: 245.89
Anchor: 2026-04-29 (52w Low)
ABOVE AVWAP
+17.2%
Heikin-Ashi Trend
WEAKLY BULLISH
Full data via /api/advanced/ABBV
Valuation
| Metric | Value |
|---|---|
| Market Cap | 509.50B |
| P/E (TTM) | 49.53 |
| Forward P/E | N/A |
| P/B | -111.16 |
| EPS | 5.82 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 10.3% |
| Profit Margin | 15.7% |
| ROE | N/A |
| Debt/Equity | N/A |
| Current Ratio | 0.87 |
| Dividend Yield | 2.4% |
| Payout Ratio | N/A |
| Beta | 0.19 |
Trading Data
288.24
Open
288.24
Day High
288.24
Day Low
7.88M
Volume (1.6x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)